Risk factors for fragility fractures in patients with immunobullous diseases on long-term systemic glucocorticoids
- PMID: 39635574
- PMCID: PMC11616581
- DOI: 10.4081/dr.2024.9813
Risk factors for fragility fractures in patients with immunobullous diseases on long-term systemic glucocorticoids
Keywords: corticosteroids; geriatric dermatology; immunobullous disease; osteoporosis.
Conflict of interest statement
Conflict of interest: the authors declare no potential conflict of interest.
References
-
- Tee SI, Yosipovitch G, Chan YC, et al. . Prevention of glucocorticoid-induced osteoporosis in immunobullous diseases with alendronate: a randomized, double-blind, placebo-controlled study. Archives of dermatology. 2012;148:307-14. - PubMed
-
- Buckley L, Guyatt G, Fink HA, et al. . 2017 American College of Rheumatology guideline for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis & rheumatology. 2017;69:1521-37. - PubMed
LinkOut - more resources
Full Text Sources